Perkins Capital Management Inc has filed its 13F form on February 11, 2025 for Q4 2024 where it was disclosed a total value porftolio of $104 Million distributed in 81 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $8.02M, Eli Lilly & CO with a value of $7.65M, Microsoft Corp with a value of $5.23M, Axogen, Inc. with a value of $4.3M, and Idexx Laboratories Inc with a value of $4.01M.

Examining the 13F form we can see an increase of $2.07M in the current position value, from $102M to 104M.

Below you can find more details about Perkins Capital Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $104 Million
Healthcare: $61.3 Million
Technology: $24.6 Million
Communication Services: $8.21 Million
Consumer Defensive: $5.06 Million
Industrials: $2.96 Million
Energy: $950,000
Financial Services: $645,000

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 81
  • Current Value $104 Million
  • Prior Value $102 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 11, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 6 stocks
  • Additional Purchases 20 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 45 stocks
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.